To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Incidence and pathogenesi… - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

Contact form


Note! If you want an answer on a question you must specify your email address

Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults.

Journal article
Authors Birgit Sköldenberg
Elisabeth Aurelius
Anders Hjalmarsson
Farideh Sabri
Marianne Forsgren
Birger Andersson
Annika Linde
Örjan Strannegård
Marie Studahl
Lars Hagberg
Lars Rosengren
Published in Journal of neurology
Volume 253
Issue 2
Pages 163-70
ISSN 0340-5354
Publication year 2006
Published at Institute of Neuroscience and Physiology, Department of Clinical Neuroscience and Rehabilitation
Institute of Biomedicine, Department of Infectious Medicine
Pages 163-70
Language en
Keywords Adolescent, Adult, Aged, Aged, 80 and over, Case-Control Studies, Cytokines, cerebrospinal fluid, Encephalitis, Herpes Simplex, cerebrospinal fluid, epidemiology, pathology, physiopathology, Enzyme-Linked Immunosorbent Assay, methods, Female, Follow-Up Studies, Glial Fibrillary Acidic Protein, cerebrospinal fluid, Herpes Simplex, cerebrospinal fluid, genetics, Humans, Incidence, Male, Middle Aged, Phosphopyruvate Hydratase, cerebrospinal fluid, Prospective Studies, RNA, Messenger, biosynthesis, Recurrence, Retrospective Studies, Reverse Transcriptase Polymerase Chain Reaction, methods, Time Factors
Subject categories Medical and Health Sciences


OBJECTIVES: To study the occurrence of relapse of herpes simplex encephalitis (HSE) and to find out whether soluble activity markers in cerebrospinal fluid (CSF) indicate direct viral or immune- mediated events. METHODS: A consecutive series of 32 adult survivors of HSE were followed to determine the incidence of clinical relapse of HSE. Four patients had neurological deterioration interpreted as relapsing HSE. Four non-relapsing HSE cases were selected as matched controls. Fifty nine batched, paired CSF and serum samples from the eight HSE patients were analysed for soluble activity markers, predominantly cytokines and mediators (interferon-gamma, soluble CD8, tumour necrosis factor-alpha, and interleukin-10), amount of HSV-DNA and markers of glial and neuronal destruction (neurofilament protein, glial fibrillary acidic protein, S-100-beta, and neuron specific enolase). RESULTS: Relapse of HSE was diagnosed in 3 of 26 (12 %) acyclovir-treated patients (5 episodes during 6.1 years of followup) and in 1 of 6 vidarabine-recipients. All relapses occurred from 1 to 4 months after acute HSE, except for a second relapse after 3.3 years in one patient. Computer tomography at relapses revealed few abnormalities apart from those found during the primary disease. Intravenous acyclovir and corticosteroids were given for 7-21 days in all the relapse patients. All relapse patients seemed to recover to the pre-relapse condition. HSV-DNA was demonstrated in CSF in all patients during the acute stage but not in any of 13 CSF samples taken during relapse phases. The HSV viral load during the acute stage of HSE was not higher or of longer duration in the relapsing patients than in the non-relapsing HSE controls. The levels of sCD8 were increased in nearly all CSF samples tested with peaks of sCD8 at one month of acute HSE. In all episodes of relapse, sCD8 peaks were detected during the first week at high levels. CSF levels of neuron-specific enolase, S-100 and glial fibrillary acidic protein were markedly lower at relapse than at the acute stage of HSV-1 encephalitis. CONCLUSION: The lack of demonstrable HSV DNA in CSF, the lack of acute CSF signs and the lack of signs of neural and glia cells destruction indicate that a direct viral cytotoxicity is not the major pathogenic mechanism in relapse. Instead, the pronounced CSF proinflammatory immunological response and the relative lack of CSF anti-inflammatory cytokine IL-10 response suggest immunologically-mediated pathogenicity.

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?